Fund Holdings — Foresite Capital Management VI LLC

Total Portfolio Value:
$182.55M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)2,221,4742,221,4740$63.71M$54.40M29.80%-$9.31M
Alumis Inc4,202,6704,202,6700$33.03M$25.80M14.14%-$7.23M
Centessa Pharmaceuticals IncADS1,253,3791,253,3790$20.99M$18.02M9.87%-$2.97M
Rapt Therapeutics Inc12,500,00012,500,0000$19.75M$15.25M8.35%-$4.50M
Akero Therapeutics Inc365,000365,0000$10.15M$14.78M8.09%+$4.62M
Edgewise Therapeutics, Inc.(EWTX)585,000585,0000$15.62M$12.87M7.05%-$2.75M
Bicara Therapeutics Inc950,000950,0000$16.55M$12.38M6.78%-$4.17M
Structure Therapeutics IncADS420,000420,0000$11.39M$7.27M3.98%-$4.12M
Allogene Therapeutics Inc3,448,2753,448,2750$7.34M$5.03M2.76%-$2.31M
Corvus Pharmaceuticals, Inc.(CRVS)1,581,2331,581,2330$8.46M$5.03M2.75%-$3.43M
Cullinan Therapeutics, Inc.(CGEM)634,558634,5580$7.73M$4.80M2.63%-$2.93M
Kymera Therapeutics, Inc.(KYMR)146,332146,3320$5.89M$4.01M2.19%-$1.88M
CASI Pharmaceuticals, Inc.(CASIF)1,329,3831,329,3830$3.76M$2.87M1.57%-$890.7K
Viridian Therapeutics, Inc.(VRDN)1,9741,9740$37.8K$26.6K0.01%-$11.2K
Page 1 of 1